2017
DOI: 10.2174/0929867324666170223153115
|View full text |Cite
|
Sign up to set email alerts
|

Epigenetic Modulation Using Small Molecules - Targeting Histone Acetyltransferases in Disease

Abstract: Histone acetyltransferases (HATs) are epigenetic drivers that catalyze the acetyl transfer from acetyl-CoA to lysines of both histone and non-histone substrates and thereby induce transcription either by chromatin remodeling or direct transcription factor activation. Histone deacetylases (HDACs) conduct the reverse reaction to counter HAT activity. Physiological processes such as cell cycle progression or apoptosis require a thoroughly balanced equilibrium of the interplay between acetylation and deacetylation… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
20
0
1

Year Published

2017
2017
2023
2023

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 26 publications
(22 citation statements)
references
References 163 publications
1
20
0
1
Order By: Relevance
“…Both enzymes have an ~160-residue HAT domain and a C-terminal bromodomain and have a strong preference, among histones, for acetylation of H3K14 [38]. Both HATs are ubiquitously expressed, with GCN5 functioning as part of the SAGA and ATAC complexes [38,39], whereas PCAF can be autoacetylated or acetylated by p300, and both HATs can acetylate a variety of non-histone, as well as histone, proteins [40]. Gcn5-deleted mice die during embryogenesis, with failure to develop dorsal mesodermal structures, including the neural tube [18,19].…”
Section: Discussionmentioning
confidence: 99%
“…Both enzymes have an ~160-residue HAT domain and a C-terminal bromodomain and have a strong preference, among histones, for acetylation of H3K14 [38]. Both HATs are ubiquitously expressed, with GCN5 functioning as part of the SAGA and ATAC complexes [38,39], whereas PCAF can be autoacetylated or acetylated by p300, and both HATs can acetylate a variety of non-histone, as well as histone, proteins [40]. Gcn5-deleted mice die during embryogenesis, with failure to develop dorsal mesodermal structures, including the neural tube [18,19].…”
Section: Discussionmentioning
confidence: 99%
“…Inhibitors targeting HATs are considered as potential drugs for cancer therapy [ 34 , 35 ]. Typically, these compounds inhibit two or more paralogous enzymes like CBP/p300 or PCAF/GCN5 [ 36 ].…”
Section: Discussionmentioning
confidence: 99%
“…The proteins of the histone acetylation cycle have clinical significance in cancer (Somech et al, 2004;Jain and Barton, 2017;Richters and Koehler, 2017) and have attracted interest as potential druggable targets. For example, translocation of BRD-containing BRD4 to NUTM1 in human cells generates an oncoprotein that drives a rare and aggressive form of squamous cell carcinoma, NUT midline carcinoma (NMC) (French et al, 2004).…”
Section: The Histone Acetylation Cycle and Its Relevance To Human Dismentioning
confidence: 99%